BlackRock Fund Advisors - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 233 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.68 and the average weighting 0.4%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$180,125,000
+11.4%
1,772,705
+11.9%
0.03%0.0%
Q3 2016$161,744,000
-7.5%
1,584,794
+8.1%
0.03%
-15.4%
Q2 2016$174,906,000
+18.6%
1,466,467
+6.5%
0.04%
+14.7%
Q1 2016$147,463,000
+0.5%
1,377,004
+1.8%
0.03%0.0%
Q4 2015$146,696,000
+26.6%
1,353,035
+0.0%
0.03%
+13.3%
Q3 2015$115,844,000
-10.2%
1,352,528
+5.8%
0.03%
-3.2%
Q2 2015$128,938,000
+25.4%
1,277,878
-4.1%
0.03%
+24.0%
Q1 2015$102,788,000
+51.3%
1,333,008
+4.4%
0.02%
+47.1%
Q4 2014$67,951,000
+16.6%
1,277,041
+2.9%
0.02%
+6.2%
Q3 2014$58,298,000
-27.9%
1,240,648
-4.5%
0.02%
-30.4%
Q2 2014$80,909,000
-11.2%
1,298,901
-4.1%
0.02%
-14.8%
Q1 2014$91,151,000
+31.5%
1,355,000
+2.8%
0.03%
+28.6%
Q4 2013$69,336,000
+120.8%
1,318,179
+81.7%
0.02%
+90.9%
Q3 2013$31,396,000
+32.8%
725,419
+14.8%
0.01%
+22.2%
Q2 2013$23,636,000631,9800.01%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
BVF INC/IL 2,626,160$138,136,00024.17%
KNOTT DAVID M 1,292,566$67,988,972,00013.87%
GROW Partners, LLC 200,000$10,520,0006.41%
Opaleye Management Inc. 90,000$4,860,000,0003.82%
OBERWEIS ASSET MANAGEMENT INC/ 213,317$11,220,0002.72%
First Light Asset Management, LLC 60,242$3,169,0002.69%
Timpani Capital Management LLC 98,956$5,205,0002.59%
Iguana Healthcare Management, LLC 75,000$3,945,0002.25%
Eventide Asset Management 134,400$7,069,0002.18%
ASHFORD CAPITAL MANAGEMENT INC 215,223$11,321,0002.16%
View complete list of LIGAND PHARMACEUTICALS INC shareholders